Application Notes

Cellastim S – Reconstitution Application Note

rHSA Reconstitution Video Protocol

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

OptiVERO – Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media

OptiVERO – Formulation of a blood-free and chemically defined virus production media for VERO cells

OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Blog

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

Solving the Vaccine Supply Challenge

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Journal Articles (DOI Links)

Improvements in Viral Vector Manufacturing Process with Chemical Definition of Cell Culture Media & Excipients

Posters

Cellastim S – Optimizing Antibody Production in Animal-Free Media with the Supplementation of Recombinant Human Albumin

Improving Vaccine Development, Performance, and Stability with Recombinant HSA Excipient

Product Brochures

2021 Product Catalog

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

ITSE+A – Specifications

Cellastim S – Product Specifications

SDS

ITSE AF – Safety Data Sheet

Use Guidelines

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Formulation and production of a blood‐free and chemically defined virus production media for VERO cells

Optimization of Albumin Inclusion in Cell Culture Media – Fatty Acid Profiles